Peter Crock, chief executive of Cann Group, which cultivates cannabis for medicinal and research purposes, said medicinal marijuana production had been stymied by limited demand from Australian patients. "While the Australian patient base is growing, it is very small," Crock told Reuters. "Being able ...
read more here
Delivered by @can_nab_is
No comments:
Post a Comment